Drugs / A/H1N1 pandemic influenza vaccine (non- adjuvanted)
A/H1N1 pandemic influenza vaccine (non- adjuvanted)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01053143 | Jan → Aug 2010 | swine influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | A/H1N1 pandemic influenza vaccine (non- adjuvanted) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01053143 ↗ |
| Modality | Vaccine | “A/H1N1 pandemic influenza vaccine (non- adjuvanted)” NCT01053143 ↗ |
| Route | Intramuscular | “Intramuscular” NCT01053143 ↗ |